Ferric Oxyhydroxide Patent Expiration
Ferric Oxyhydroxide was first introduced by Sanofi Aventis Us Llc
Ferric Oxyhydroxide Patents
Given below is the list of patents protecting Ferric Oxyhydroxide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Velphoro |
US10624855 (Pediatric) | Pharmaceutical composition, comprising phosphate binder particles | May 26, 2035 | Vifor Fresenius |
| Velphoro |
US11234938 (Pediatric) | Pharmaceutical composition, comprising phosphate binder particles | May 26, 2035 | Vifor Fresenius |
| Velphoro |
US11446252 (Pediatric) | Pharmaceutical composition, comprising phosphate binder particles | May 26, 2035 | Vifor Fresenius |
| Velphoro | US10624855 | Pharmaceutical composition, comprising phosphate binder particles | Nov 26, 2034 | Vifor Fresenius |
| Velphoro | US11234938 | Pharmaceutical composition, comprising phosphate binder particles | Nov 26, 2034 | Vifor Fresenius |
| Velphoro | US11446252 | Pharmaceutical composition, comprising phosphate binder particles | Nov 26, 2034 | Vifor Fresenius |
| Velphoro |
US9561251 (Pediatric) | Pharmaceutical compositions | Jul 23, 2030 | Vifor Fresenius |
| Velphoro | US9561251 | Pharmaceutical compositions | Jan 23, 2030 | Vifor Fresenius |
| Velphoro |
US10682376 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10695367 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10925896 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10925897 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US10933090 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US11013761 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro |
US11013762 (Pediatric) | Pharmaceutical compositions | May 13, 2029 | Vifor Fresenius |
| Velphoro | US10682376 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10695367 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10925896 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10925897 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US10933090 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US11013761 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US11013762 | Pharmaceutical compositions | Nov 13, 2028 | Vifor Fresenius |
| Velphoro | US6174442 | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent |
Jun 12, 2020
(Expired) | Vifor Fresenius |
| Dexferrum | US5624668 | Iron dextran formulations |
Sep 29, 2015
(Expired) | Am Regent |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ferric Oxyhydroxide's patents.
Latest Legal Activities on Ferric Oxyhydroxide's Patents
Given below is the list recent legal activities going on the following patents of Ferric Oxyhydroxide.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10695367 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10682376 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Oct, 2023 | US10624855 |
| Patent Issue Date Used in PTA Calculation Critical | 20 Sep, 2022 | US11446252 |
| Recordation of Patent Grant Mailed Critical | 20 Sep, 2022 | US11446252 |
| Email Notification Critical | 01 Sep, 2022 | US11446252 |
| Issue Notification Mailed Critical | 31 Aug, 2022 | US11446252 |
| Application Is Considered Ready for Issue Critical | 23 Aug, 2022 | US11446252 |
| Dispatch to FDC | 23 Aug, 2022 | US11446252 |
| Issue Fee Payment Received Critical | 12 Aug, 2022 | US11446252 |
Ferric Oxyhydroxide's Family Patents
Explore Our Curated Drug Screens
Ferric Oxyhydroxide Generic API Manufacturers
Only one generic application has been filed for Ferric Oxyhydroxide.
Given below is the list of companies who have filed for Ferric Oxyhydroxide generic, along with the locations of their manufacturing plants worldwide.
1. WEST-WARD PHARMS INT
West-ward Pharmaceuticals International Ltd has filed for 1 generic for Ferric Oxyhydroxide. This eq 62.5mg iron/5ml (eq 12.5mg iron/ml) version comes by the name SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) | injectable | Prescription | INJECTION | AB | Mar 31, 2011 |